P Dugan, VR Rao - Neurostimulation for Epilepsy, 2023 - Elsevier
Three neurostimulation therapies have been approved for use in drug-resistant focal epilepsies: vagus nerve stimulation (VNS), deep brain stimulation (DBS), and responsive …
Z Ren, Y Li, T Yu, D Ni, G Zhang, W Du… - Neural Regeneration …, 2017 - journals.lww.com
Brief-pulse stimulation at 50 Hz has been shown to terminate afterdischarges observed in epilepsy patients. However, the optimal pulse stimulation parameters for terminating cortical …
Z Hu, X Wang, K Zhong - Neuroscience Bulletin, 2019 - Springer
Drug resistance is one of the most serious issues in epilepsy. Despite using various appropriate anti-epileptic drugs (AEDs), 30% of epilepsy patients are still drugresistant. The …
I Mihály, T Molnár, ÁJ Berki, RB Bod, K Orbán-Kis… - 2021 - search.proquest.com
Temporal lobe epilepsy (TLE) is characterized by changes in interneuron numbers in the hippocampus. Deep brain stimulation (DBS) is an emerging tool to treat TLE seizures …
F Zhang, Y Zheng, C Yu, HC Wu… - 2019 IEEE Biomedical …, 2019 - ieeexplore.ieee.org
Single-target responsive neural stimulation might underlie limited efficacy for seizure suppression since broad networks in the brain are involved in the epileptic activities. In order …
Z Chen, Y Gong, C Xu, Z Zhang, S Zhang, X Li, X Qiu… - papers.ssrn.com
Background: One-third of patients with epilepsy are resistant to pharmacological interventions. Early prediction of pharmacoresistance is therapeutically significant to …
M Zare, A Shojaei, SJ Mirnajarizadeh - 2020 - cabidigitallibrary.org
Epilepsy is the most common neurological disease with no definitive method in treatment. Notably, the main way to treat and control epileptic seizures is drug therapy. However, about …